| 000 | 00995 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517022058.0 | ||
| 264 | 0 | _c20151201 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a1838-7640 | ||
| 024 | 7 |
_a10.7150/thno.10824 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNicolosi, Pier Andrea | |
| 245 | 0 | 0 |
_aTheranostic impact of NG2/CSPG4 proteoglycan in cancer. _h[electronic resource] |
| 260 |
_bTheranostics _c2015 |
||
| 300 |
_a530-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntigens _xanalysis |
| 650 | 0 | 4 |
_aDiagnostic Tests, Routine _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aNeoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aProteoglycans _xanalysis |
| 700 | 1 | _aDallatomasina, Alice | |
| 700 | 1 | _aPerris, Roberto | |
| 773 | 0 |
_tTheranostics _gvol. 5 _gno. 5 _gp. 530-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.7150/thno.10824 _zAvailable from publisher's website |
| 999 |
_c24704491 _d24704491 |
||